[Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*; D011897:Random Allocation
D000959:Antihypertensive Agents; D011412:Propanolamines; D009248:Nadolol; D001539:Bendroflumethiazide
Trattamento dell'ipertensione arteriosa essenziale con nadololo e bendroflumetiazide.